.
It was already reported10) that Chartreusin exhibited a therapeutic activity against experimental mouse tumors. On the other hand, mutagenic activities of Chartreusin have not been reported. Therefore, its mutagenic activity was tested with the use of Ames system9) using Salmonella typhimurium TA1537 and TA1538 without the metabolic activation. The dose response curves on the Salmonella show that Chartreusin is mutagenic to bacteria (Fig. 1) .
FIG. 1. Dose Response Curves of Chartreusin (F-67
Substance) on Salmonella typhimurium TA1537 and TA 1538.
If it is permitted that cancer chemotherapeutic agents have a little mutagenic activity, the screening with Recassay system may be an advantageous procedure for the isolation of anticarcinogenic agents.
